fda announcement tirzepatide says the weight-loss drug shortage is over FDA approves new weight-loss drug

Most BPC-157 products sold online are research-grade and labeled not for human use, meaning they are not tested for purity, sterility, or accurate dosing

That foundation keeps patients engaged for the long haul

Saeidi, N

PlexusDx compounded tirzepatide ($289/mo month-to-month, or from $249/mo on the 6-month plan) pairs with optional genetic testing to support a more informed provider conversation

Brand transparency Look for brands that share certificate of analysis, ingredient sourcing, and clinical data

Gastric Emptying Delay: By slowing the rate at which your stomach empties food into the small intestine, GLP-1 extends the window of nutrient absorption and prolongs satiety signals